Provided by Tiger Fintech (Singapore) Pte. Ltd.

COSMOS HEALTH INC

0.3176
-0.0174-5.19%
Post-market: 0.32060.0030+0.94%19:58 EDT
Volume:192.07K
Turnover:60.59K
Market Cap:8.64M
PE:-0.27
High:0.3455
Open:0.3455
Low:0.2801
Close:0.3350
Loading ...

Cosmos Health Reports FY24 Revenue $54.34M Up From $53.38M YoY

Benzinga
·
17 Apr

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

GlobeNewswire
·
10 Apr

Cosmos Health launches Sky Premium Life in Albania, secures $300,000 order

TIPRANKS
·
08 Apr

Cosmos Health Launches Sky Premium Life in Albania Through Partnership With Pharma Cell; Secures Initial $300,000 Order

THOMSON REUTERS
·
08 Apr

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

GlobeNewswire
·
08 Apr

Cosmos Health Inc. (NASDAQ:COSM) Might Not Be As Mispriced As It Looks After Plunging 31%

Simply Wall St.
·
04 Mar

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

ACCESS Newswire
·
27 Feb

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency

Benzinga
·
25 Feb

Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock

Simply Wall St.
·
20 Feb

BRIEF-Cosmos Health Announces It Will Not Proceed With An Offering Under Its Form S-1

Reuters
·
19 Feb

Cosmos Health Announces It Will Not Proceed With an Offering Under Its Form S-1

THOMSON REUTERS
·
19 Feb

Cosmos Health will not proceed with offering under Form S-1

TIPRANKS
·
18 Feb

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

ACCESS Newswire
·
18 Feb

Cosmos enters final development phase of CCX0722 weight managment solution

TIPRANKS
·
11 Feb

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

ACCESS Newswire
·
11 Feb

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

ACCESS Newswire
·
11 Feb

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

ACCESS Newswire
·
10 Feb

Cosmos Health's Cana Labs Signs 10-Year Manufacturing Deal With Provident Pharmaceuticals

MT Newswires Live
·
07 Feb

Cosmos Health secures 10-year contract manufacturing order from Provident

TIPRANKS
·
07 Feb

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

ACCESS Newswire
·
07 Feb